PCF Leadership

• Gina B. Carithers, President & CEO
• Howard R. Soule, PhD, Executive Vice President, Chief Science Officer, Lori and Michael Milken Chair
• Stuart Holden, MD, Medical Director
• Andrea Miyahira, PhD, Senior Director, Global Research & Scientific Communications
• Development & Translation Committee, PCF Board of Directors

Surgical Urologic Oncology

• William Aronson, MD, University of California, Los Angeles
• Neil Bander, MD, Weill Cornell Medicine
• Christopher Barbieri, MD, PhD, Weill Cornell Medicine
• Wayne Brisbane, MD, University of California, Los Angeles
• Brett Carver, MD, Memorial Sloan Kettering Cancer Center
• Carissa Chu, MD, University of California, San Francisco
• Alexander Cole, MD, Harvard: Brigham and Women’s Hospital
• Claire de la Calle, MD, University of Washington
• Harveer Dev, MD, PhD, University of Cambridge
• Renu Eapen, MBBS, FRACS, Peter MacCallum Cancer Centre
• Adam Feldman, MD, Harvard: Massachusetts General Hospital
• Stephen Freedland, MD, Cedars Sinai Medical Center
• Christopher Gaffney, MD, Memorial Sloan Kettering Cancer Center
• Isla Garraway, MD, PhD, University of California, Los Angeles
• Jeffrey Jones, MD, Michael E. DeBakey VA Medical Center
• Rakesh Heer, MBBS, PhD, Newcastle University
• Mayuko Kanayama, MD, PhD, Johns Hopkins University
• Daniel Lee, MD, Corporal Michael J. Crescenz VA Medical Center / University of Pennsylvania
• Hing Leung, MBBS, PhD, University of Glasgow – Cancer Research UK Beatson Institute
• Stacy Loeb, MD, New York University
• Todd Morgan, MD, University of Michigan
• Hao Nguyen, MD, PhD, University of California, San Francisco
• Hiten Patel, MD, MPH, Northwestern University
• Mark Preston, MD, MPH, University of California, San Diego
• Robert Reiter, MD, University of California, Los Angeles
• Michael Rothberg, MD, Duke University
• Ashwin Sachdeva, MBBS, PhD, University of Manchester
• Simpa Salami, MD, University of Michigan
• Mark Salji, PhD, MB Bchir, University of Glasgow – Cancer Research UK Beatson Institute
• Martin Sanda, MD, Emory University
• Udit Singhal, MD, University of Michigan
• Vasilis Stavrinides, MD, PhD, University College London
• Takayuki Sumiyoshi, MD, PhD, Kyoto University
• Jeffrey Tosoian, MD, Vanderbilt University
• Quoc-Dien Trinh, MD, Harvard: Brigham and Women’s Hospital
• Samuel Washington III, MD, University of California, San Francisco
• Adam Weiner, MD, Cedars-Sinai Medical Center

Medical Oncology and Treatment Sciences

• Rahul Aggarwal, MD, University of California, San Francisco
• Joshi Alumkal, MD, University of Michigan
• Emmanuel Antonarakis, MD, University of Minnesota
• Ana Aparicio, MD, The University of Texas MD Anderson Cancer Center
• Andrew Armstrong, MD, Duke University
• Mohammad Atiq, MD, National Institutes of Health
• Gerhardt Attard, MD, PhD, University College London
• Sylvan Baca, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Steven Balk, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
• Himisha Beltran, MD, Harvard: Dana-Farber Cancer Institute
• Hala Borno, MD, University of California San Francisco
• Rohit Bose, MD, PhD, University of California San Francisco
• Frank Cackowski, MD, PhD, Wayne State University
• Megan Caram, MD, University of Michigan
• Maria Carlo, MD, Memorial Sloan Kettering Cancer Center
• Elena Castro, MD, PhD, Spanish National Cancer Research Centre
• Michael Cheng, MD, University of California San Francisco
• Atish Choudhury, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Catherine Coombs, MD, University of California, Irvine
• Matthew Dallos, MD, Memorial Sloan Kettering Cancer Center
• Tanya Dorff, MD, City of Hope
• Johann de Bono, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
• David Einstein, MD, Harvard: Beth Israel Deaconess Medical Center
• Ivan de Kouchkovsky, MD, University of California San Francisco
• Samuel Denmeade, MD, Johns Hopkins University
• Matthew Freedman, MD, Harvard: Dana-Farber Cancer Institute
• Terence Friedlander, MD, University of California, San Francisco
• Brad Gallent, MD, PhD, Cedars-Sinai Medical Center
• Daniel George, MD, Duke University
• Veda Giri, MD, Yale University
• Jun Gong, MD, Cedars-Sinai Medical Center
• Julie Graff, MD, VA Portland Health Care System
• Emily Grist, MBBS, University College London Cancer Institute
• Andrew Hahn, MD, The University of Texas MD Anderson Cancer Center
• Anis Hamid, MBBS, University of Melbourne
• Elisabeth Heath, MD, Mayo Clinic Comprehensive Cancer Center
• Andrew Hsieh, MD, Fred Hutchinson Cancer Research Center
• Maha Hussain, MD, Northwestern University
• Nick James, MBBS, PhD, Institute of Cancer Research, Royal Marsden Hospital
• Anuradha Jayaram, MBBS, University College London
• Anthony Michael Joshua, MD, PhD, Kinghorn Cancer Centre
• Carl June, MD, University of Pennsylvania
• William K. Kelly, DO, Thomas Jefferson University
• Vadim Koshkin, MD, University of California, San Francisco
• Edmond Kwan, MBBS, PhD, Vancouver Prostate Centre
• Andrew Laccetti, MD, Memorial Sloan Kettering Cancer Center
• Joshua Lang, MD, University of Wisconsin
• John Lee, MD, PhD, Fred Hutchinson Cancer Center
• Christopher Logothetis, MD, The University of Texas MD Anderson Cancer Center
• Mark Markowski, MD, PhD, Johns Hopkins University
• Catherine Marshall, MD, Johns Hopkins University
• Joaquin Mateo, MD, PhD, Vall d’Hebron Institute of Oncology
• Kara Maxwell, MD, PhD, University of Pennsylvania (Corporal Michael J. Crescenz VA Medical Center)
• Nabiel Mir, MBBS, University of Chicago
• Alicia Morgans, MD, MPH, Harvard: Dana-Farber Cancer Institute
• Michael Morris, MD, Memorial Sloan Kettering Cancer Center
• Lucia Nappi, MD, PhD, University of British Columbia
• Vivek Narayan, MD, University of Pennsylvania
• Peter Nelson, MD, Fred Hutchinson Cancer Research Center
• David Oh, MD, PhD, University of California, San Francisco
• Jacob Orme, MD, PhD, Mayo Clinic
• Ravi Parikh, MD, Emory University
• Alec Paschalis, MBBS, Institute of Cancer Research
• Kenneth Pienta, MD, Johns Hopkins University
• Mark Pomerantz, MD, Harvard: Dana-Farber Cancer Institute
• Edwin Posadas, MD, Cedars-Sinai Medical Center
• Dana Rathkopf, MD, Memorial Sloan Kettering Cancer Center
• Praful Ravi, MD, Harvard: Dana-Farber Cancer Institute
• Pasquale Rescigno, MD, Candiolo Institute of Cancer Research
• Matthew Rettig, MD, University of California, Los Angeles
• Oliver Sartor, MD, Tulane University
• Philip Saylor, MD, Harvard: Massachusetts General Hospital
• Tahlia Scheinberg, MBBS, FRACP, Chris O’Brien Lifehouse
• Howard Scher, MD, Memorial Sloan Kettering Cancer Center
• Martin Schoen, MD, MPH, Saint Louis Veterans Affairs Medical Center
• Laura Sena, MD, PhD, Johns Hopkins University
• Marina Sharifi, MD, PhD, University of Wisconsin
• Nima Sharifi, MD, Cleveland Clinic
• Adam Sharp, MD, PhD, Institute of Cancer Research, Royal Marsden Hospital
• Bilal Siddiqui, MD, The University of Texas MD Anderson Cancer Center
• Martin Sjöström, MD, PhD, Lund University
• Eric Small, MD, University of California, San Francisco
• Matthew Smith, MD, PhD, Harvard: Massachusetts General Hospital
• Walter Stadler, MD, City of Hope, Chicago
• Christopher Sweeney, MBBS, The University of Adelaide
• Russell Szmulewitz, MD, University of Chicago
• Scott Tagawa, MD, Weill Cornell Medicine
• Mary-Ellen Taplin, MD, Harvard: Dana-Farber Cancer Institute
• Amy Taylor, MD, University of Wisconsin
• Salomon Tendler, MD, PhD, Memorial Sloan Kettering Cancer Center
• Alok Tewari, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Sofie Tolmeijer, PhD, University of British Columbia
• Phoebe Tsao, MD, University of Michigan
• Eliezer Van Allen, MD, Harvard: Dana-Farber Cancer Institute
• David VanderWeele, MD, PhD, Northwestern University
• Varadha B. Venkadakrishan, PhD, Harvard: Dana-Farber Cancer Institute
• Evan Yu, MD, University of Washington
• Xiao Wei, MD, Harvard: Dana-Farber Cancer Institute
• David Wise, MD, PhD, New York University
• Samir Zaidi, MD, PhD, Memorial Sloan Kettering Cancer Center
• Xiaolin Zhu, MD, PhD, University of California, San Francisco

Immunotherapy

• Andrea Alimonti, MD, Institute of Oncology Research
• Nathaniel Brennen, PhD, Johns Hopkins University
• Lawrence Fong, MD, Fred Hutchinson Cancer Center
• Stephen Forman, MD, City of Hope
• James Gulley, MD, PhD, National Cancer Institute
• Fatima Karzai, MD, National Cancer Institute
• Haydn Kissick, PhD, Emory University
• Marcin Kortylewski, PhD, City of Hope
• Aram Lyu, PhD, Fred Hutchinson Cancer Center
• Ravi Madan, MD, National Cancer Institute
• Douglas McNeel, MD, PhD, University of Wisconsin
• Amy Moran, PhD, Oregon Health & Science University
• John Murad, PhD, City of Hope
• Paul Nghiem, MD, PhD, University of Washington
• Russell Pachynski, MD, Washington University
• Eileen Parkes, MD, PhD, University of Oxford
• Saul Priceman, PhD, City of Hope
• William Redmond, PhD, Providence Portland Medical Center
• David Sanin, PhD, Johns Hopkins University
• Padmanee Sharma, MD, PhD, The University of Texas, MD Anderson Cancer Center
• Eugene Shenderov, MD, PhD, Johns Hopkins University
• Jinjun Shi, PhD, Harvard: Brigham and Women’s Hospital
• Nour Shobaki, PhD, PharmD, University of Pennsylvania
• Sumit Subudhi, MD, PhD, The University of Texas, MD Anderson Cancer Center
• Jennifer Wu, PhD, Northwestern University
• Jelani Zarif, PhD, Johns Hopkins University
• Nicholas Zorko, MD, PhD, University of Minnesota

Genomics / Bioinformatics

• Saud AlDubayan, MD, Harvard: Dana-Farber Cancer Institute
• Ahmed Abbas Elmahdi, PhD, The University of Texas, MD Anderson Cancer Center
• Juan Arriaga, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Paul Boutros, PhD, MBA, University of California, Los Angeles
• Marcin Cieslik, PhD, University of Michigan
• Francesca Demichelis, PhD, Universita’ degli Studi di Trento
• Michael Evans, PhD, University of California, San Francisco
• Roni Haas, PhD, University of California, Los Angeles
• William Hahn, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Vanessa Hayes, PhD, The University of Sydney
• Hansen (Housheng) He, UHN / Princess Margaret Cancer Center
• Hannelore Heemers, PhD, Cleveland Clinic
• Christopher Haiman, ScD, University of Southern California
• Franklin Huang, MD, PhD, University of California, San Francisco
• Francesca Lorenzin, PhD, Università degli Studi di Trento
• Jun Luo, PhD, Johns Hopkins University
• Christopher Maher, PhD, Washington University
• Antonina Mitrofanova, PhD, Rutgers Cancer Institute of New Jersey
• Yashar Niknafs, PhD, University of Michigan
• Colin Pritchard, MD, PhD, University of Washington
• David Quigley, PhD, University of California, San Francisco
• Keyan Salari, MD, PhD, Harvard: Massachusetts General Hospital
• Woogwang Sim, PhD, University of California, San Francisco
• Alexandra Sokolova, MD, Oregon Health & Science University
• Elizabeth Wasmuth, PhD, University of Texas Health Science Center at San Antonio
• Alexander Wyatt, PhD, Vancouver Prostate Centre

Basic Science

• Cory Abate-Shen, PhD, Columbia University
• Sarki Abdulkadir, MD, PhD, Northwestern University
• Sarah Amend, PhD, Johns Hopkins University
• Mohammad Asim, PhD, University of Surrey
• Vipul Bhatia, PhD, University of California, Los Angeles
• Charles Bieberich, PhD, University of Maryland
• Chad Brenner, PhD, University of Michigan
• George Butler, PhD, University College London
• Qi Cao, PhD, The Methodist Hospital Research Institute
• Hongwu Chen, PhD, University of California, Davis
• Yu Chen, MD, PhD, Memorial Sloan Kettering Cancer Center
• Lisa Chesner, PhD, University of California, San Francisco
• Jonathan Chou, MD, PhD, University of California, San Francisco
• Scott Dehm, PhD, University of Minnesota
• Christina Dieli-Conwright, PhD, MPH, Harvard: Dana-Farber Cancer Institute
• Eleonora Dondossola, PhD, The University of Texas MD Anderson Cancer Center
• Dimitrios Doultsinos, PhD, University of Oxford
• Asmaa Elkenawi, PhD, Indiana University
• Leigh Ellis, PhD, Cedars Sinai Medical Center
• Claire Fletcher, PhD, Imperial College London
• Luke Gilbert, PhD, University of California, San Francisco
• Andrew Goldstein, MD, University of California, Los Angeles
• David Goodrich, PhD, Roswell Park Cancer Institute
• Rebecca Graff, ScD, University of California, San Francisco
• Geraldine Gueron, PhD, Iquibicen-Conicet
• Amanda Hargrove, PhD, Duke University
• Christopher Heaphy, PhD, Boston University
• Anastasia Hepburn, PhD, Newcastle University
• Haojie Huang, PhD, Mayo Clinic
• Christina Jamieson, PhD, University of California, San Diego
• Janggun Jo, PhD, University of Michigan
• Sushant Kachhap, MD, Johns Hopkins University
• Dong-Woo Kang, PhD, Harvard: Dana-Farber Cancer Institute
• Kalpana Kannan, PhD, Baylor College of Medicine
• Salma Kaochar, PhD, Baylor College of Medicine
• Wouter Karthous, PhD, Memorial Sloan Kettering Cancer Center
• Steven Kregel, PhD, Loyola University Chicago
• Anson Ku, PhD, National Institutes of Health
• Rajendra Kumar, PhD, Johns Hopkins University
• Estefania Labanca, PhD, The University of Texas MD Anderson Cancer Center
• David Labbé, PhD, Harvard: Dana-Farber Cancer Institute
• Hung-Ming Lam, PhD, University of Washington
• Lucia Languino, PhD, Thomas Jefferson University
• Aaron LeBeau, PhD, University of Wisconsin
• Amanda Leiter, MD, Icahn School of Medicine at Mount Sinai Hospital
• Haolong Li, PhD, University of California, San Francisco
• Hui Li, PhD, University of California, San Francisco
• Jia Li, PhD, Columbia University Medical Center
• Shyh-Dar Li, PhD, The University of British Columbia
• Weiping Li, PhD, Columbia University Medical Center
• Neil Lin, PhD, University of California, Los Angeles
• Shawn Lupold, PhD, Johns Hopkins University
• Everardo Macias, PhD, Duke University
• Nupam Mahajan, PhD, Washington University
• Alan Meeker, MD, PhD, Johns Hopkins University
• Nigel Mongan, PhD, University of Nottingham
• Ping Mu, PhD, University of Texas Southwestern
• Lucia Nappi, MD, PhD, University of British Columbia
• Alexandros Papachristodoulou, PhD, Rutgers Biomedical and Health Sciences
• Apurva Pandey, PhD, University of California, San Francisco
• Jung Wook Park, PhD, Duke University
• Abhijit Parolia, PhD, University of Michigan
• Ramon Parsons, MD, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Steven Patierno, PhD, Duke University
• Robert Patton, PhD, Fred Hutchinson Cancer Center
• Sethuramasundaram Pitchiaya, PhD, University of Michigan
• Stephen Plymate, MD, University of Washington
• Larysa Poluben, PhD, Harvard: Beth Israel Deaconess Medical Center
• Sonam Raj, PhD, National Institutes of Health
• Veronica Rodriguez-Bravo, PhD, Mayo Clinic
• Cara Schafer, PhD, Center for Prostate Disease Research
• Matthew Schiewer, PhD, Thomas Jefferson University
• Daniel Schmidt, MD, PhD, Harvard: Beth Israel Deaconess Medical Center
• Luke Selth, PhD, University of Adelaide
• Galina Semenova, MD, PhD, University of California, Los Angeles
• Karen Sfanos, PhD, Johns Hopkins University
• Ayesha Shafi, PhD, HJF – Henry Jackson Foundation for the Advancement of Military Medicine / Uniformed Services University
• Michael Shen, PhD, Columbia University
• Yusuke Shiozawa, MD, PhD, Wake Forest School of Medicine
• Raunak Shrestha, PhD, University of California, San Francisco
• Adam Sowalsky, PhD, National Cancer Institute
• William Storck, PhD, University of Michigan
• Tanya Stoyanova, PhD, Stanford University
• Jean Tien, PhD, University of Michigan
• Anna Trigos, PhD, Peter MacCallum Cancer Centre
• Shaomeng Wang, PhD, University of Michigan
• Yuzhuo Wang, PhD, BC Cancer Agency
• Alexander Wurzer, PhD, Technical University of Munich
• Lanbo Xiao, PhD, University of Michigan
• Li Xin, PhD, University of Washington
• Kexin Xu, PhD, University of Texas Health Science Center at San Antonio
• Srinivasan Yegnasubramanian, MD, PhD, Johns Hopkins University
• Noah Younger, MD, PhD, University of California, San Francisco
• Jindan Yu, MD, PhD, Emory University
• Di Zhao, PhD,  The University of Texas MD Anderson Cancer Center
• Ming-Ming Zhou, PhD, Icahn School of Medicine at Mount Sinai Hospital
• Amina Zoubeidi, PhD, University of British Columbia

Radiation Oncology

• James Byrne, MD, PhD, University of Iowa
• William Chen, MD, University of California, San Francisco
• Alan D’Andrea, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Edward Christopher Dee, MD, Memorial Sloan Kettering Cancer Center
• Adam Dicker, MD, PhD, Thomas Jefferson University
• Jason Efstathiou, MD, PhD, Harvard: Massachusetts General Hospital
• Julian Hong, MD, University of California, San Francisco
• Sophia Kamran, MD, Harvard: Massachusetts General Hospital
• Ariel Marciscano, MD, Harvard: Massachusetts General Hospital
• David Miyamoto, MD, PhD, Harvard: Massachusetts General Hospital
• Kent Mouw, MD, PhD, Harvard: Dana-Farber Cancer Institute
• Paul Nguyen, MD, Harvard: Harvard: Dana-Farber Cancer Institute
• Nicholas Nickols, MD, PhD, University of California, Los Angeles
• Ryan Park, MD, The University of Texas MD Anderson Cancer Center
• Sagar Patel, MD, Emory University
• Zachery Reichert, MD, PhD, University of Michigan
• Tyler Seibert, MD, PhD, University of California, San Diego
• Daniel Spratt, MD, Case Western Reserve
• Philip Sutera, MD, University of Rochester
• Shervin Tabrizi, MD, Harvard: Massachusetts General Hospital
• Phuoc Tran, MD, PhD, Johns Hopkins University
• Scott Williams, MD, Peter MacCallum Cancer Centre
• David Yang, MD, Harvard: Dana-Farber Cancer Institute

Molecular Imaging (Radiology)

• Mehmet Bilen, MD, Emory University
• Steve Cho, MD, University of Wisconsin
• Peter Choyke, MD, National Cancer Institute
• Jeremy Durack, MD, Memorial Sloan Kettering Cancer Center
• Michael Evans, PhD, University of California, San Francisco
• Robert Flavell, MD, PhD, University of California, San Francisco
• Francesco Giganti, MD, University College London
• Michael Hahn, MD, PhD, University of California, San Diego
• Stefanie Hectors, PhD, Weill Cornell Medicine
• Thomas Hope, MD, University of California, San Francisco
• Joseph Ippolito, MD, PhD, Washington University
• Price Jackson, PhD, Peter MacCallum Cancer Centre
• Tamara Jamaspishvili, MD, PhD, State University of New York Upstate Medical University
• Robert Jeraj, PhD, University of Wisconsin
• Stephanie Harmon, PhD, National Cancer Institute
• John Kurhanewicz, PhD, University of California, San Francisco
• Steven Larson, MD, Memorial Sloan Kettering Cancer Center
• Jason Lewis, PhD, Memorial Sloan Kettering Cancer Center
• Glenn Liu, MD, University of Wisconsin
• Raquel Perez-Lopez, PhD, Vall d’Hebron Institute of Oncology
• Daniel Thorek, PhD, Johns Hopkins University
• Huihui Ye, MD, University of California, Los Angeles

Molecular Pathology

• Gustavo Ayala, MD, University of Texas Health Science Center
• Tarek Bismar, MD, University of Calgary
• Angelo DeMarzo, MD, PhD, Johns Hopkins University
• Chien-Kuang (Cornelia) Ding, MD, PhD, University of California, San Francisco
• Michael Haffner, MD, Fred Hutchinson Cancer Research Center
• Jiaoti Huang, MD, PhD, Duke University
• Michael Ittmann, MD, PhD, Baylor College of Medicine
• Tamara Jamaspishvili, MD, PhD, State University of New York (SUNY) Upstate Medical University
• Beatrice Knudsen, MD, PhD, University of Utah
• Massimo Loda, MD, Weill Cornell Medicine
• Tamara Lotan, MD, Johns Hopkins University
• Rohit Mehra, MD, University of Michigan
• David Rickman, PhD, Weill Cornell Medicine
• Antonio Rodriguez-Calero, MD, University of Bern
• Mark Rubin, MD, University of Bern
• Jeffrey Simko, MD, PhD, University of California, San Francisco
• Huihui Ye, MD, University of California, Los Angeles

Epidemiology / Observational Research

• Burcu Darst, PhD, Fred Hutchinson Cancer Center
• Susan Halabi, PhD, Duke University
• Ashley Holly, PhD, MBA, University of Miami
• Sarah Holt, PhD, Fred Hutchinson Cancer Research Center
• Corinne Joshu, PhD, Johns Hopkins University
• Stacey Kenfield, ScD, University of California, San Francisco
  
• Lorelei Mucci, ScD, MPH, Harvard School of Public Health
• Kathryn Penney, ScD, Harvard: Dana-Farber Cancer Institute
• Anna Plym, PhD, Karolinska Institutet
• Timothy Rebbeck, PhD, Harvard: Dana-Farber Cancer Institute
• Konrad Stopsack, MD, MPH, Memorial Sloan Kettering Cancer Center
• Leanne Woods-Burnham, PhD, Morehouse School of Medicine

Nuclear Medicine

• James Buteau, MD, University of Melbourne
• Jeremie Calais, MD, University of California, Los Angeles
• Johannes Czernin, MD, University of California, Los Angeles
• Louise Emmett, MD, St Vincent’s Hospital Sydney, Australia
• Andrei Gafita, MD, Johns Hopkins University
• Jan Grimm, MD, PhD, Memorial Sloan Kettering Cancer Center
• Michael Hofman, MBBS, Peter MacCallum Cancer Centre